Tamil Nadu pooled all public drug buying into TNMSC and cut prices about 30%

In the early 1990s, Tamil Nadu's government hospitals faced chronic shortages, sporadic supply and loose, easily diverted packaging, and a spurious-drugs scandal exposed how little quality control existed. In 1994 the state set up the Tamil Nadu Medical Services Corporation under the Companies Act: one company buying drugs for the entire public system, with R. Poornalingam as its architect.

TNMSC changed the structure of the market. About 250 essential generics were tendered annually with technical bids evaluated before price bids; the first batch of every accepted drug, plus random warehouse samples, was tested by a panel of about 11 laboratories; suppliers who failed were blacklisted for four years (60-70 companies by 2010). Strip and blister packaging labelled in English and Tamil made government drugs hard to divert — patients in a Kanchipuram survey could name their medicines instead of describing loose tablets wrapped in newspaper.

The quiet masterstroke was the passbook, modelled on a bank passbook. Every clinic, polyclinic and hospital received one: demand at the nearest warehouse, the withdrawal is entered, and the entry feeds a management information system tracking inventory across 25-plus warehouses that releases supplier payment within 15 days. Fast payment and visible stock killed both the shortages and the graft that shortages justified.

Results were stark. Procurement costs fell about 30% (the state later cited 36% of the drug budget saved). Ten strips of ciprofloxacin that cost Rs 525 in 1992-94 cost Rs 88 by 2002-03; 100 Norfloxacin tablets fell from Rs 290 to Rs 51. By the NSSO's 2004 survey, an inpatient's average drug cost in a Tamil Nadu public hospital was Rs 102, against Rs 3,268 in Haryana and Rs 3,187 in Rajasthan. India's union health ministry adopted the model as a national benchmark.

Central buying, ruthless testing, passbook inventory

Consolidating ~250 tenders into one buyer ended each hospital's weak bargaining position and made the state's full demand visible to competing suppliers.

Technical-then-price bid evaluation kept unqualified suppliers from winning on price alone; first-batch and random warehouse testing kept quality from degrading after award.

Paying within 15 days removed the late-payment excuse that historically greased kickbacks, while the four-year blacklist made a failed batch ruinously expensive.

The passbook turned thousands of clinics into live inventory sensors, so reordering ran on recorded withdrawals rather than phone calls and guesswork.

Blister packaging and Tamil labelling closed the diversion loophole that had made government drugs a wholesale source for private sellers.

Procurement reform is about who holds information: pool demand, pay fast, test batches, give every clinic a passbook that makes stock visible. Any fragmented buyer can copy those four moves.

TNMSC is still running three decades on: its 2024-25 policy note lists 313 essential drugs, 280 surgical items and 326 speciality drugs across 32 warehouses, and in 2024 it took over anti-TB drug procurement when central supply failed. The union health ministry consulted TNMSC's founders for national TB, malaria and vaccine procurement; modelled corporations spread across Indian states and abroad. It is not flawless — a 2024 CAG audit flagged Rs 11.12 crore of short-shelf-life medicines expiring in storage — but the World Bank and WHO have repeatedly endorsed the mechanism.